Abstract
The aim of pharmacological treatment of endometriosis is to reduce estrogen levels, which may be achieved using gestagens or GnRH-agonists. The effects of the different hormones are mainly the same, while side effects differ. If the GnRH-agonist dose is modified, or if a low dose of estrogen and/or gestagen is given in addition, the hypo-estrogenic side effects of GnRH-agonists can be reduced. Surgical treatment can often be performed in conjunction with diagnostic laparoscopy. Supplementary hormonal treatment may postpone recurrence. Because endometriosis is in many women a chronically recurring disorder, continuity in the doctor-patient relationship is essential.
MeSH terms
-
Analgesics / administration & dosage
-
Continuity of Patient Care
-
Danazol / administration & dosage
-
Endometriosis / drug therapy
-
Endometriosis / pathology
-
Endometriosis / surgery
-
Endometriosis / therapy*
-
Estrogen Antagonists / administration & dosage
-
Estrogen Antagonists / adverse effects
-
Female
-
Gonadotropin-Releasing Hormone / administration & dosage
-
Gonadotropin-Releasing Hormone / adverse effects
-
Hormones / administration & dosage
-
Hormones / adverse effects
-
Humans
-
Laparoscopy
-
Nafarelin / administration & dosage
-
Nafarelin / adverse effects
-
Progestins / administration & dosage
-
Progestins / adverse effects
-
Recurrence
Substances
-
Analgesics
-
Estrogen Antagonists
-
Hormones
-
Progestins
-
Nafarelin
-
Gonadotropin-Releasing Hormone
-
Danazol